Evidence map›Paper›PMID 36352387›Full record

Trial reportBMC pulmonary medicine2022

Starting HMV at home: a reasonable option for many patients?

Ries J M van den Biggelaar, A Hazenberg, N A M Cobben, M A Gaytant, D A M P J Gommers, P J Wijkstra

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ries J M van den BiggelaarDepartment of Pulmonary Diseases, Department of Intensive Care Medicine and Home Mechanical Ventilation, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands. r.vandenbiggelaar@erasmusmc.nl.
A HazenbergDepartment of Pulmonary Diseases/Home Mechanical Ventilation, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
N A M CobbenDepartment of Pulmonary Diseases/Home Mechanical Ventilation, University Medical Centre, Maastricht, the Netherlands.
M A GaytantDepartment of Pulmonary Diseases/Home Mechanical Ventilation, University Medical Centre, Utrecht, the Netherlands.
D A M P J GommersDepartment of Pulmonary Diseases, Department of Intensive Care Medicine and Home Mechanical Ventilation, Erasmus Medical Centre Rotterdam, Rotterdam, The Netherlands.
P J WijkstraDepartment of Pulmonary Diseases/Home Mechanical Ventilation, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.

Funding

ZonMw 837002501
6 · The paper itself

Abstract

BACKGROUND AND

objectiveIn the current study, we undertook a more detailed exploration of the reasons why patients undergoing HMV were screened out of a recently published study in order to better understand how applicable home initiation of HMV is under real life conditions.

methodsAll referred patients who had an indication for starting HMV were screened to participate in the Homerun study. In this trial 512 patients were screened out of the study. Those patients not enrolled in the trial were divided into the following 3 groups: (1) those not fulfilling the inclusion criteria; 2) those meeting the exclusion criteria and 3) those excluded on the basis of medical or organisation reasons. Each group was then further divided into those who would likely have been suitable for initiation of HMV at home in real world practice and those who were unsuitable.

resultsBased on inclusion criteria (group 1) 116 patients could not start HMV in real life, while this was 245 patients in the study. Based on the exclusion criteria (group 2) 11 patients could not start in real life while this was 79 in the study. One hundred and eighty-eight could not be enrolled in the study due to medical and organisational reasons ( group 3), while in real life this was only 95.

conclusionThis study indicates that more than 55% of patients who did not participate in the Homerun study could have started HMV at home in real life.

Indexed as

Home Care ServicesRespiratory InsufficiencyHumansRespiration, ArtificialHealth care organizationHome mechanical ventilationPatient selectionTelemonitoring

Identifiers

PMID36352387
PMCPMC9648039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.